Richard J Head (Richard Head)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Capillary Electrophoresis

Top Venues

Pharmacology research & perspectives

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Richard J Head, Marko E Popović, Jennifer H Martin
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"? Pharmacology research & perspectives 12 (4) (2024)
Richard J Head, Marko E Popović, Jennifer H Martin
Has the human biological interaction with SARS-CoV2 variants entered a pliant "Faustian bargain"? Pharmacology research & perspectives 12 (4) (2024)
Bevyn Jarrott, Richard J Head, Kirsty G Pringle, Eugenie R Lumbers, Jennifer H Martin
"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacology research & perspectives 10 (1) (2022)
Jennifer H Martin, Richard J Head
Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology. Pharmacology research & perspectives 10 (1) (2022)
Richard J Head, Eugenie R Lumbers, Bevyn Jarrott, Felix Tretter, Gary Smith, Kirsty G Pringle, Saiful Islam, Jennifer H Martin
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. Pharmacology research & perspectives 10 (1) (2022)
Jennifer H Martin, Julian Clark, Richard J Head
Buying time: Drug repurposing to treat the host in COVID-19H. Pharmacology research & perspectives 8 (4) (2021)
Saiful Islam, Shudong Wang, Nikola A Bowden, Jennifer H Martin, Richard J Head
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target. British journal of clinical pharmacology (2021)
Jennifer H Martin, Richard J Head
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19. British journal of clinical pharmacology 87 (3) (2020)